| Year |
Citation |
Score |
| 2016 |
Puchalapalli M, Zeng X, Mu L, Anderson A, Hix Glickman L, Zhang M, Sayyad MR, Mosticone Wangensteen S, Clevenger CV, Koblinski JE. NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice. Plos One. 11: e0163521. PMID 27662655 DOI: 10.1371/Journal.Pone.0163521 |
0.338 |
|
| 2012 |
Zeng X, Zhang H, Oh A, Zhang Y, Yee D. Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor. Breast Cancer Research and Treatment. 133: 117-26. PMID 21850397 DOI: 10.1007/S10549-011-1713-X |
0.673 |
|
| 2012 |
Zeng X, Zheng J, Feeney Y, Harrington K, Clevenger C. Abstract 3836: Enhancement of doxorubicin cytotoxicity in breast cancer by NIM811, A non-immunosuppressive cyclosporine A analog Cancer Research. 72: 3836-3836. DOI: 10.1158/1538-7445.Am2012-3836 |
0.477 |
|
| 2011 |
Zheng J, Fang F, Zeng X, Medler TR, Fiorillo AA, Clevenger CV. Negative cross talk between NFAT1 and Stat5 signaling in breast cancer. Molecular Endocrinology (Baltimore, Md.). 25: 2054-64. PMID 21964595 DOI: 10.1210/Me.2011-1141 |
0.374 |
|
| 2010 |
Fang F, Zheng J, Galbaugh TL, Fiorillo AA, Hjort EE, Zeng X, Clevenger CV. Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells. Journal of Molecular Endocrinology. 44: 319-29. PMID 20237142 DOI: 10.1677/Jme-09-0140 |
0.37 |
|
| 2010 |
Zhang H, Fagan DH, Zeng X, Freeman KT, Sachdev D, Yee D. Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation. Oncogene. 29: 2517-27. PMID 20154728 DOI: 10.1038/Onc.2010.17 |
0.632 |
|
| 2010 |
Clevenger C, Zheng J, Harrington K, Zeng X. Abstract P2-19-04: Anti-Jak2 and Breast Cancer Activity of NIM811, a Non-Immunosuppressive Cyclosporine A Analog Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P2-19-04 |
0.442 |
|
| 2009 |
Zhang H, Zeng X, Li Q, Gaillard-Kelly M, Wagner CR, Yee D. Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore. British Journal of Cancer. 101: 71-9. PMID 19491901 DOI: 10.1038/Sj.Bjc.6605103 |
0.551 |
|
| 2009 |
Zeng X, Sachdev D, Zhang H, Gaillard-Kelly M, Yee D. Sequencing of type I insulin-like growth factor receptor inhibition affects chemotherapy response in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2840-9. PMID 19351773 DOI: 10.1158/1078-0432.Ccr-08-1401 |
0.638 |
|
| 2009 |
Zhang H, Zeng X, Yee D. Comparative breast tumor imaging to identify the expression of type I IGF receptor (IGF1R) by anti-IGF1R antibody-conjugated small molecule fluorophore or quantum dotsin vivo. Cancer Research. 69: 6001. DOI: 10.1158/0008-5472.Sabcs-6001 |
0.443 |
|
| 2009 |
Zeng X, Sachdev D, Zhang H, Yee D. Sequencing of type I IGF receptor (IGF1R) inhibition affects chemotherapy response in vitro and in vivo. Cancer Research. 69: 3122. DOI: 10.1158/0008-5472.Sabcs-3122 |
0.484 |
|
| 2009 |
Zeng X, Buck E, Yee D. A Type I Insulin-Like Growth Factor Receptor Kinase Inhibitor (PQIP) Enhances the Cytotoxicity of Doxorubicin in Human Cancer Cell Lines. Cancer Research. 69: 6110-6110. DOI: 10.1158/0008-5472.Sabcs-09-6110 |
0.618 |
|
| 2009 |
Yee D, Zhang X, LaPara K, Fagan D, Ibrahim Y, Zhang H, Zeng X, Becker M, Sachdev D. 58 Inhibition of IGF signalling as cancer therapy European Journal of Cancer Supplements. 7: 17. DOI: 10.1016/S1359-6349(09)70061-8 |
0.558 |
|
| 2007 |
Zeng X, Yee D. Insulin-like growth factors and breast cancer therapy. Advances in Experimental Medicine and Biology. 608: 101-12. PMID 17993235 DOI: 10.1007/978-0-387-74039-3_7 |
0.692 |
|
| Show low-probability matches. |